Cargando…

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?

Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM...

Descripción completa

Detalles Bibliográficos
Autores principales: Alenazi, Aqeel M., Alhowimel, Ahmed S., Alshehri, Mohammed M., Alqahtani, Bader A., Alhwoaimel, Norah A., Segal, Neil A., Kluding, Patricia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137010/
https://www.ncbi.nlm.nih.gov/pubmed/37189487
http://dx.doi.org/10.3390/diagnostics13081386
_version_ 1785032356131766272
author Alenazi, Aqeel M.
Alhowimel, Ahmed S.
Alshehri, Mohammed M.
Alqahtani, Bader A.
Alhwoaimel, Norah A.
Segal, Neil A.
Kluding, Patricia M.
author_facet Alenazi, Aqeel M.
Alhowimel, Ahmed S.
Alshehri, Mohammed M.
Alqahtani, Bader A.
Alhwoaimel, Norah A.
Segal, Neil A.
Kluding, Patricia M.
author_sort Alenazi, Aqeel M.
collection PubMed
description Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA.
format Online
Article
Text
id pubmed-10137010
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101370102023-04-28 Osteoarthritis and Diabetes: Where Are We and Where Should We Go? Alenazi, Aqeel M. Alhowimel, Ahmed S. Alshehri, Mohammed M. Alqahtani, Bader A. Alhwoaimel, Norah A. Segal, Neil A. Kluding, Patricia M. Diagnostics (Basel) Review Diabetes mellitus (DM) and osteoarthritis (OA) are chronic noncommunicable diseases that affect millions of people worldwide. OA and DM are prevalent worldwide and associated with chronic pain and disability. Evidence suggests that DM and OA coexist within the same population. The coexistence of DM in patients with OA has been linked to the development and progression of the disease. Furthermore, DM is associated with a greater degree of osteoarthritic pain. Numerous risk factors are common to both DM and OA. Age, sex, race, and metabolic diseases (e.g., obesity, hypertension, and dyslipidemia) have been identified as risk factors. These risk factors (demographics and metabolic disorder) are associated with DM or OA. Other possible factors may include sleep disorders and depression. Medications for metabolic syndromes might be related to the incidence and progression of OA, with conflicting results. Given the growing body of evidence indicating a relationship between DM and OA, it is vital to analyze, interpret, and integrate these findings. Therefore, the purpose of this review was to evaluate the evidence on the prevalence, relationship, pain, and risk factors of both DM and OA. The research was limited to knee, hip, and hand OA. MDPI 2023-04-10 /pmc/articles/PMC10137010/ /pubmed/37189487 http://dx.doi.org/10.3390/diagnostics13081386 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Alenazi, Aqeel M.
Alhowimel, Ahmed S.
Alshehri, Mohammed M.
Alqahtani, Bader A.
Alhwoaimel, Norah A.
Segal, Neil A.
Kluding, Patricia M.
Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title_full Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title_fullStr Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title_full_unstemmed Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title_short Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
title_sort osteoarthritis and diabetes: where are we and where should we go?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137010/
https://www.ncbi.nlm.nih.gov/pubmed/37189487
http://dx.doi.org/10.3390/diagnostics13081386
work_keys_str_mv AT alenaziaqeelm osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT alhowimelahmeds osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT alshehrimohammedm osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT alqahtanibadera osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT alhwoaimelnoraha osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT segalneila osteoarthritisanddiabeteswhereareweandwhereshouldwego
AT kludingpatriciam osteoarthritisanddiabeteswhereareweandwhereshouldwego